212 related articles for article (PubMed ID: 33694292)
1. The immune landscape during the tumorigenesis of cervical cancer.
Wang Y; He M; Zhang G; Cao K; Yang M; Zhang H; Liu H
Cancer Med; 2021 Apr; 10(7):2380-2395. PubMed ID: 33694292
[TBL] [Abstract][Full Text] [Related]
2. Adenocarcinoma of the Uterine Cervix Shows Impaired Recruitment of cDC1 and CD8
Rotman J; Heeren AM; Gassama AA; Lougheed SM; Pocorni N; Stam AGM; Bleeker MCG; Zijlmans HJMAA; Mom CH; Kenter GG; Jordanova ES; de Gruijl TD
Clin Cancer Res; 2020 Jul; 26(14):3791-3802. PubMed ID: 32220890
[TBL] [Abstract][Full Text] [Related]
3. Dissecting the Single-Cell Transcriptome Network of Immune Environment Underlying Cervical Premalignant Lesion, Cervical Cancer and Metastatic Lymph Nodes.
Li C; Hua K
Front Immunol; 2022; 13():897366. PubMed ID: 35812401
[TBL] [Abstract][Full Text] [Related]
4. Immune evasion before tumour invasion in early lung squamous carcinogenesis.
Mascaux C; Angelova M; Vasaturo A; Beane J; Hijazi K; Anthoine G; Buttard B; Rothe F; Willard-Gallo K; Haller A; Ninane V; Burny A; Sculier JP; Spira A; Galon J
Nature; 2019 Jul; 571(7766):570-575. PubMed ID: 31243362
[TBL] [Abstract][Full Text] [Related]
5. The differences in immune features and genomic profiling between squamous cell carcinoma and adenocarcinoma - A multi-center study in Chinese patients with uterine cervical cancer.
Li J; Xue X; Zhang Y; Ding F; Wu W; Liu C; Xu Y; Chen H; Ou Q; Shao Y; Li X; Wu F; Wu X
Gynecol Oncol; 2023 Aug; 175():133-141. PubMed ID: 37356314
[TBL] [Abstract][Full Text] [Related]
6. The immune microenvironment in vulvar (pre)cancer: review of literature and implications for immunotherapy.
Abdulrahman Z; Kortekaas KE; De Vos Van Steenwijk PJ; Van Der Burg SH; Van Poelgeest MI
Expert Opin Biol Ther; 2018 Dec; 18(12):1223-1233. PubMed ID: 30373410
[TBL] [Abstract][Full Text] [Related]
7. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
[TBL] [Abstract][Full Text] [Related]
8. Identification of cervical cancer stem cells using single-cell transcriptomes of normal cervix, cervical premalignant lesions, and cervical cancer.
Zhang T; Zhuang L; Muaibati M; Wang D; Abasi A; Tong Q; Ma D; Jin L; Huang X
EBioMedicine; 2023 Jun; 92():104612. PubMed ID: 37224771
[TBL] [Abstract][Full Text] [Related]
9. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
[TBL] [Abstract][Full Text] [Related]
10. [Value of 4-quadrant biopsies under colposcopy for detecting precancerous lesions in cervical cancer screening].
Zhao Y; Song Y; Zhao F; Zhang W; Li L; Chen F; Chen W; Pan Q; Shen G; Qiao Y
Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):875-9. PubMed ID: 26887523
[TBL] [Abstract][Full Text] [Related]
11. Sequencing-based transcriptome analysis reveals diversification of immune response- and angiogenesis-related expression patterns of early-stage cervical carcinoma as compared with high-grade CIN.
Kurmyshkina OV; Dobrynin PV; Kovchur PI; Volkova TO
Front Immunol; 2023; 14():1215607. PubMed ID: 37731500
[TBL] [Abstract][Full Text] [Related]
12. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
Hilders CG; Munoz IM; Nooyen Y; Fleuren GJ
Gynecol Oncol; 1995 Jun; 57(3):366-75. PubMed ID: 7774840
[TBL] [Abstract][Full Text] [Related]
13. Comparative transcriptomic profiling in HPV-associated cervical carcinogenesis: Implication of MHC class II and immunoglobulin heavy chain genes.
Balasubramaniam SD; Wong KK; Oon CE; Balakrishnan V; Kaur G
Life Sci; 2020 Sep; 256():118026. PubMed ID: 32615187
[TBL] [Abstract][Full Text] [Related]
14. Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma.
Sheu BC; Hsu SM; Ho HN; Lin RH; Torng PL; Huang SC
Cancer; 1999 Oct; 86(8):1537-43. PubMed ID: 10526283
[TBL] [Abstract][Full Text] [Related]
15. Isoantigens ABO in cervical neoplasia.
Stafl A; Mattingly RF
Gynecol Oncol; 1972 Nov; 1(1):26-35. PubMed ID: 4669441
[No Abstract] [Full Text] [Related]
16. Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment area.
Heeren AM; de Boer E; Bleeker MC; Musters RJ; Buist MR; Kenter GG; de Gruijl TD; Jordanova ES
Oncotarget; 2015 Oct; 6(32):32484-93. PubMed ID: 26431490
[TBL] [Abstract][Full Text] [Related]
17. Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer Patients.
Wang Q; Vattai A; Vilsmaier T; Kaltofen T; Steger A; Mayr D; Mahner S; Jeschke U; Hildegard Heidegger H
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671013
[TBL] [Abstract][Full Text] [Related]
18. Systematic identification of key genes and pathways in the development of invasive cervical cancer.
Niu G; Wang D; Pei Y; Sun L
Gene; 2017 Jun; 618():28-41. PubMed ID: 28341182
[TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation of CDH13, DAPK1 and TWIST1 genes in precancerous and cancerous lesions of the uterine cervix.
Missaoui N; Hmissa S; Trabelsi A; Traoré C; Mokni M; Dante R; Frappart L
Pathol Res Pract; 2011 Jan; 207(1):37-42. PubMed ID: 21129853
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory Stroma of Lymphoepithelioma-like Carcinoma of the Cervix: Immunohistochemical Study of 3 Cases and Review of the Literature.
Philippe A; Rassy M; Craciun L; Naveaux C; Willard-Gallo K; Larsimont D; Veys I
Int J Gynecol Pathol; 2018 Sep; 37(5):482-487. PubMed ID: 28985196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
